The Food and Drug Administration has not approved Avastin for use in the eye, and using it rather than the alternative, Lucentis, might carry an additional, although slight, safety risk.
美国食品和药品管理局还没有批准阿瓦斯汀用于眼部治疗，使用它来代替雷珠单抗可能会产生额外的安全风险，尽管这一风险也许很轻微。
Objective To discuss the thrombolysis effect, drug using window, and safety for cerebral infarction.
目的探讨降纤酶对脑梗死的溶栓效果、用药时间窗及安全性。
ABSTRACT: OBJECTIVE: To provide reference for ensuring the drug safety using for children in family.
摘要：目的：为保障儿童家庭用药安全提供参考。
应用推荐